Milan - Delayed Quote EUR
Vertex Pharmaceuticals Incorporated (1VRTX.MI)
438.15
+7.00
+(1.62%)
As of April 10 at 1:09:49 PM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 341.53k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ALTSHULER DAVID Officer | Sale at price 510.00 per share. | Direct | 1,647,810 | Mar 13, 2025 |
| ALTSHULER DAVID Officer | Sale at price 500.00 per share. | Direct | 1,615,500 | Mar 10, 2025 |
| WAGNER CHARLES F JR Chief Financial Officer | Sale at price 500.00 per share. | Direct | 1,649,000 | Mar 10, 2025 |
| TATSIS OURANIA Officer | Sale at price 499.99 per share. | Direct | 1,620,968 | Mar 10, 2025 |
| TATSIS OURANIA Officer | Sale at price 485.49 per share. | Direct | 1,970,118 | Mar 4, 2025 |
| ALTSHULER DAVID Officer | Sale at price 490.00 per share. | Direct | 1,583,190 | Mar 3, 2025 |
| ALTSHULER DAVID Officer | Sale at price 480.00 per share. | Direct | 610,560 | Feb 27, 2025 |
| ATKINSON EDWARD MORROW III Chief Technology Officer | Sale at price 475.34 per share. | Direct | 1,259,651 | Feb 27, 2025 |
| TATSIS OURANIA Officer | Sale at price 475.34 per share. | Direct | 251,930 | Feb 27, 2025 |
| ALTSHULER DAVID Officer | Sale at price 480.95 per share. | Direct | 407,846 | Feb 25, 2025 |
| AMBROSE KRISTEN Officer | Sale at price 480.95 per share. | Direct | 425,160 | Feb 25, 2025 |
| ATKINSON EDWARD MORROW III Officer | Sale at price 480.95 per share. | Direct | 849,839 | Feb 25, 2025 |
| TATSIS OURANIA Officer | Sale at price 480.95 per share. | Direct | 170,256 | Feb 25, 2025 |
| ALTSHULER DAVID Officer | Sale at price 480.00 per share. | Direct | 533,280 | Feb 20, 2025 |
| AMBROSE KRISTEN Officer | Sale at price 455.06 per share. | Direct | 305,345 | Feb 18, 2025 |
| TATSIS OURANIA Officer | Sale at price 455.06 per share. | Direct | 111,035 | Feb 18, 2025 |
| BILLER JONATHAN PRIM Officer | Sale at price 455.06 per share. | Direct | 754,034 | Feb 18, 2025 |
| TATSIS OURANIA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| BOZIC CARMEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| AMBROSE KRISTEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| ATKINSON EDWARD MORROW III Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| ALTSHULER DAVID Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| ARBUCKLE STUART A Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| KEWALRAMANI RESHMA Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| BILLER JONATHAN PRIM Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| WAGNER CHARLES F JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| SACHDEV AMIT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| LEIDEN JEFFREY M Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| AMBROSE KRISTEN Officer | Sale at price 459.83 per share. | Direct | 632,726 | Feb 11, 2025 |
| ATKINSON EDWARD MORROW III Chief Technology Officer | Sale at price 459.83 per share. | Direct | 803,323 | Feb 11, 2025 |
| TATSIS OURANIA Officer | Sale at price 459.83 per share. | Direct | 142,547 | Feb 11, 2025 |
| BILLER JONATHAN PRIM Officer | Sale at price 459.87 per share. | Direct | 1,578,734 | Feb 11, 2025 |
| BOZIC CARMEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| AMBROSE KRISTEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| ATKINSON EDWARD MORROW III Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| ALTSHULER DAVID Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| ARBUCKLE STUART A Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| KEWALRAMANI RESHMA Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| WAGNER CHARLES F JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| SACHDEV AMIT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| LEIDEN JEFFREY M Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| ALTSHULER DAVID Officer | Sale at price 478.56 per share. | Direct | 7,178 | Nov 15, 2024 |
| WAGNER CHARLES F JR Chief Financial Officer | Sale at price 518.27 per share. | Direct | 1,554,810 | Nov 11, 2024 |
| KEWALRAMANI RESHMA Chief Executive Officer | Sale at price 515.00 per share. | Direct | 7,826,970 | Nov 8, 2024 |
| BILLER JONATHAN PRIM Officer | Sale at price 461.66 per share. | Direct | 461,198 | Oct 2, 2024 |
| BHATIA SANGEETA N Director | Conversion of Exercise of derivative security at price 152.74 per share. | Direct | 98,670 | Aug 30, 2024 |
| LEIDEN JEFFREY M Officer and Director | Sale at price 499.00 per share. | Direct | 1,888,216 | Aug 30, 2024 |
| BHATIA SANGEETA N Director | Sale at price 500.00 per share. | Direct | 323,000 | Aug 30, 2024 |
| BHATIA SANGEETA N Director | Conversion of Exercise of derivative security at price 152.74 per share. | Direct | 197,340 | Aug 8, 2024 |
| BHATIA SANGEETA N Director | Sale at price 466.29 per share. | Direct | 602,447 | Aug 8, 2024 |
Related Tickers
ICY.F Incyte Corporation
50.88
+0.24%
RGO.F Regeneron Pharmaceuticals, Inc.
512.20
-0.62%
GALT Galectin Therapeutics Inc.
1.3400
+0.75%
PROK ProKidney Corp.
0.9101
+21.49%
ACHV Achieve Life Sciences, Inc.
2.4300
-2.02%
ONVO Organovo Holdings, Inc.
2.0400
+1.49%
TIL Instil Bio, Inc.
20.52
+24.44%
CMND Clearmind Medicine Inc.
0.9764
-2.36%
INCY Incyte Corporation
58.00
+1.08%
ATAI Atai Life Sciences N.V.
1.5200
+3.40%